Quality of Life in Patients with Retinal Vein Occlusion: A Review of the Literature
Ophthalmologica · 04.03.2026 · 1-9
DOI: 10.1159/000551378 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Ophthalmologica, online erschienen am 04.03.2026. Verfasst von Dimitrios Kazantzis und 3 weiteren Autor:innen. Beteiligte Einrichtung: 2nd Department of Ophthalmology, Attikon University Hospital, Athens, Greece, dimitrios.kazantzis@nhs.net. Hauptthemen laut MEDLINE: Retinal Vein Occlusion, Quality of Life, Visual Acuity. Die Arbeit nennt 37 Literaturangaben.
Abstract (Originalsprache)
Background: Retinal vein occlusion (RVO) is the second most common retinal vascular disorder after diabetic retinopathy and represents a significant cause of visual loss worldwide. Beyond visual impairment, RVO can profoundly affect patients’ wellbeing and overall vision-related quality of life (QoL). Increasing evidence indicates that vision-related disability contributes to increased levels of anxiety and social limitations in affected individuals. This narrative review synthesizes current evidence on QoL outcomes in patients with RVO, highlights factors influencing psychological outcomes, and explores the role of treatment interventions in modifying patient-reported wellbeing. Summary: Across the included studies, patients with RVO reported significantly reduced vision-related QoL compared with healthy controls, as assessed by the NEI VFQ-25. Anti-vascular endothelial growth factor (VEGF) therapies, including ranibizumab, aflibercept, and bevacizumab, consistently improved QoL scores, with gains evident as early as 1 month and sustained up to 12 months. Improvements were most pronounced in visual function and daily activity subscales, although near vision, mental health, and social functioning frequently remained below normal levels. Predictors of better QoL outcomes included stereopsis, fellow eye vision, and central macular thickness reduction, while systemic comorbidities such as hypertension and diabetes were associated with poorer outcomes. Key Messages: While anti-VEGF therapy improves QoL in patients with RVO, long-term management should extend beyond vision restoration. A multidisciplinary approach – integrating ophthalmology, primary care, and psychological support – is essential to address systemic risk factors, reduce treatment burden, and improve overall wellbeing. Future studies should explore long-term QoL outcomes and evaluate strategies that support holistic, patient-centered care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 2nd Department of Ophthalmology, Attikon University Hospital, Athens, Greece, dimitrios.kazantzis@nhs.net.
- Moorfields Eye Hospital, London, UK, dimitrios.kazantzis@nhs.net.
- 2nd Department of Ophthalmology, Attikon University Hospital, Athens, Greece.
- King's College Hospital NHS Foundation Trust, London, UK.
Zitieren
APA
Kazantzis, D., Machairoudia, G., Theodossiadis, P., & Chatziralli, I. (2026). Quality of Life in Patients with Retinal Vein Occlusion: A Review of the Literature. Ophthalmologica, 1-9. https://doi.org/10.1159/000551378
Vancouver
Kazantzis D, Machairoudia G, Theodossiadis P, Chatziralli I. Quality of Life in Patients with Retinal Vein Occlusion: A Review of the Literature. Ophthalmologica. 2026:1-9. doi:10.1159/000551378
BibTeX
@article{Kazantzis2026,
author = {Kazantzis, Dimitrios and Machairoudia, Genovefa and Theodossiadis, Panagiotis and Chatziralli, Irini},
title = {Quality of Life in Patients with Retinal Vein Occlusion: A Review of the Literature},
journal = {Ophthalmologica},
year = {2026},
pages = {1--9},
doi = {10.1159/000551378}
}
EUVIMED